New HIV Prevention Injectable Recommended in Europe
A New Era in HIV Prevention: The Rise of Long-Acting Injections The recent recommendation by the European Medicines Agency (EMA) for a twice-yearly HIV prevention injection, Yeytuo (lenacapavir), marks a significant shift in the fight against HIV. This innovation, which has also been approved in the US, promises to revolutionize Pre-Exposure Prophylaxis (PrEP) and could … Read more